Setting up Pharmaceutical Laboratory Business in China: An Exploratory Study

Chua, Victor Chin Hong (2009) Setting up Pharmaceutical Laboratory Business in China: An Exploratory Study. [Dissertation (University of Nottingham only)] (Unpublished)

[img] PDF - Repository staff only - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
Download (2MB)

Abstract

This project is trying to explore the possibility of Pharmaceutical Division, Applied Sciences Group (ASG), a division in Health Sciences Authority (HSA), Ministry of Health in setting up a pharmaceutical laboratory with office in People’s Republic of China. There are several objectives in doing so but the main objective is to generate revenues in a new booming economy in Asia - China.

The author is a certified foreign expert appointed by the Mayors of Shaoxing city (2003) and Xian city (2006). I had worked in China for four years as a Head of Department and Administrator. This project seeks to affirm the critical success factors (CSFs) that HSA and other pharmaceutical/ healthcare-related organisations should be aware of when venturing into China

Two centuries ago, Napoleon warned all in that China was a ‘sleeping giant’ that ‘once awake would astonish the world’. That prediction looks like it is about to be fulfilled – look at its amazing economic growth and market size. This project was carried out to evaluate whether HSA should venture into China. Through HSA is a statutory board but there are discussions whether to privatise ASG. China is an emerging market that many cannot ignore it.

This project seeks to analyse the economic figures, trends and statistics. Interviews were carried out to collect valuable opinions by experts connected closely to China and science fields – scientists, China Embassy in Singapore, Singapore-China Business Association and Chinese lawyers located in Shanghai etc. Conversation analysis was carried out from interviewees’ comments.

At the end of this project, recommendations using country specific advantages (CSAs), firm specific advantages (FSAs) and critical success factors (CSFs) were proposed how HSA could venture into China.

Item Type: Dissertation (University of Nottingham only)
Depositing User: EP, Services
Date Deposited: 27 Jan 2010 13:51
Last Modified: 23 Oct 2016 07:17
URI: http://eprints.nottingham.ac.uk/id/eprint/23134

Actions (Archive Staff Only)

Edit View Edit View